Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Scientists of the Technical University of Munich (TUM) and the Max Planck Institute of Psychiatry have identified four new risk genes that are altered in German patients with multiple sclerosis (...

Leaky blood vessels in the brain called cerebral microbleeds are associated with increased physical and cognitive disability in patients with multiple sclerosis (MS), according to a new study by...

A radical and risky stem cell therapy has been shown to halt and even reverse some of the symptoms of those worst affected by multiple sclerosis, a condition that in many people has proved...

Oligodendrocytes, a type of brain cell that plays a crucial role in conditions such as multiple sclerosis, are more diverse than have previously been thought, according to a new study by...

Biogen has been bit by the failure of its multiple sclerosis candidate opicinumab to show efficacy in a phase II trial.

The news is disappointing as the antibody had been proposed as a...

New research claims the risk of developing multiple sclerosis increases with shift work due to circadian rhythm.

The study came from Swedish researchers who uncovered an association between...

Research from Indiana University School of Medicine has found that D3T – a compound that triggers copying of antioxidant genes and production of the antioxidant glutathione – delays disease...

A study claims newly diagnosed patients with relapsing-remitting multiple sclerosis (RRMS) showed significant improvements when treated with delayed-release dimethyl fumarate (DMF), especially in...

A study presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting in America has shown that MS patients of African descent might better benefit from treatment of...

A study investigating the safety of Tysabri in patients with early relapsing-remitting MS has been presented at the 2016 meeting of the Consortium of Multiple Sclerosis Centres (CMSC).

...

Pages

Live Chat Software by Click4Assistance UK